Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
76,313,271
-
Shares change
-
+1,667,000
-
Total reported value, excl. options
-
$3,830,944,634
-
Value change
-
+$86,495,993
-
Put/Call ratio
-
136%
-
Number of buys
-
110
-
Number of sells
-
-80
-
Price
-
$50.20
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2022
229 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2022.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76,313,271 shares
of 80,437,135 outstanding shares and own 95% of the company stock.
Largest 10 shareholders include FMR LLC (10,731,144 shares), WELLINGTON MANAGEMENT GROUP LLP (7,491,062 shares), VANGUARD GROUP INC (7,211,720 shares), BlackRock Inc. (6,108,417 shares), RTW INVESTMENTS, LP (5,620,580 shares), FRANKLIN RESOURCES INC (4,468,775 shares), ARMISTICE CAPITAL, LLC (2,900,000 shares), STATE STREET CORP (2,823,232 shares), Camber Capital Management LP (2,450,000 shares), and JANUS HENDERSON GROUP PLC (2,077,864 shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.